Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
600329
Kedudukan dalam Saham
#4374
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its... Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its subsidiaries, primarily manufactures and markets traditional Chinese medicine, Western pharmaceuticals, and various healthcare products within the People's Republic of China. Its business activities are structured into two distinct divisions: Chinese Medicine and Western Medicine. The company's operations extend beyond its core offerings to include the production and distribution of Chinese, Western, and biological pharmaceutical items. It also engages in the wholesale and retail trade of medicines, biochemical pharmaceutical products, and everyday consumer goods, in addition to managing hospitals. Furthermore, Tianjin Pharmaceutical Da Ren Tang provides a comprehensive suite of services such as logistics, inventory management, equipment installation, and drug processing. It also offers pharmaceutical inspection, testing, and advisory services. In terms of its commercial model, the company supplies its proprietary branded medicinal products directly to wholesalers. Conversely, it acquires pharmaceuticals marketed under other brands from distributors, subsequently reselling these to other wholesale clients. Established in 1992 and based in Tianjin, People's Republic of China, the company was previously known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited before adopting its current name in May 2022.
Harga Saham
$6.17
Modal Pasaran
$3.52B
Perubahan (1 hari)
-0.05%
Perubahan (1 tahun)
-1.86%
Negara
CN
Perdagangan Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)
Kategori
Healthcare
Hasil untuk Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)
Hasil pada Oct 2026 TTM: 0
Menurut laporan kewangan terkini daripada Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited dari 2001 hingga 2026
Hasil pada akhir setiap tahun
| Tahun | Hasil | Ubah |
|---|---|---|
| 2025 | $702.84M | -29.79% |
| 2024 | $1.00B | -13.82% |
| 2023 | $1.16B | -2.87% |
| 2022 | $1.20B | 10.04% |
| 2021 | $1.09B | 7.51% |
| 2020 | $1.01B | 0.64% |
| 2019 | $1.00B | 8.65% |
| 2018 | $924.41M | 5.71% |
| 2017 | $874.43M | -2.75% |
| 2016 | $899.13M | -17.54% |
| 2015 | $1.09B | -4.70% |
| 2014 | $1.14B | 15.48% |
| 2013 | $990.83M | 20.44% |
| 2012 | $822.65M | 18.08% |
| 2011 | $696.67M | 32.38% |
| 2010 | $526.25M | 24.71% |
| 2009 | $421.97M | 21.73% |
| 2008 | $346.64M | 12.07% |
| 2007 | $309.30M | 11.54% |
| 2006 | $277.30M | -10.61% |
| 2005 | $310.21M | 21.98% |
| 2004 | $254.31M | 1.95% |
| 2003 | $249.43M | 12.25% |
| 2002 | $222.22M | 20.82% |
| 2001 | $183.92M | 0.00% |
Hasil untuk syarikat atau pesaing serupa
| Syarikat | Hasil | Perbezaan Hasil | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | - |
IN
|
